News

AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...
The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...
US biotech company SparX Biopharmaceutical has signed a research agreement with Mitsubishi Tanabe Pharma America aimed at ...
He will discuss how Kernel, a software design tool that powers Asimov’s CHO Edge system, can accelerate timelines and improve titers for cell line and process development. The webinar will cover ...
Phio's one-on-one meetings with investors will take place on Wednesday and Thursday, May 21-22, 2025 and can be accessed here: REGISTRATION LINK FOR PRESENTATION OR ONE-ON-ONE MEETINGS: www.sidoti.com ...
The "Biopharmaceutical Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The Global Biopharmaceutical ...
The Company is currently conducting two additional SPC-15 studies: an IND-enabling GLP (Good Laboratory Practice)-compliant ...
Medical bioreactor market is growing due to rising demand for biopharmaceuticals, advancements in cell culture technologies, ...
Pursuant to Article 241-2 of the AMF General Regulations ( Règlement Général de l’Autorité des marchés financiers ), the purpose of this description is to present the objectives and terms of the ...
CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company focused on the development of innovative therapies, announces the signing of a binding ...
These four quality stocks trading at or near their 52-week lows come with stellar dividends that could be massive bargains ...
Viva Biotech launches AI-driven drug discovery platform, transforming new drug R&D logic, enabling one-stop innovative drug discovery: Shanghai, China Friday, May 16, 2025, 12:00 ...